Cullinan Pearl Corp.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Cullinan Pearl Corp.
Scrip
• By Mandy Jackson
Venture capital fundraising by biopharmaceutical companies plunged in the fourth quarter to $4.3bn, down from $6.2bn in the third quarter and below the $5.7bn raised in Q4 of 2022, according to the la
Scrip
• By Joseph Haas, Jung Won Shin, and Dexter Jie Yan
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Taiho To Pay $275m Up Front For CLN-081